Quarterly securities filings released on 25 August show several prominent hedge-fund managers repositioning portfolios during the second quarter of 2025, with technology, financial and health-care names drawing the most decisive moves. Egerton Capital, run by John Armitage, almost doubled its holding in Visa, raised Microsoft by 39 percent and more than doubled Capital One Financial, while trimming Amazon by 21 percent. The fund also initiated positions in Ferguson, Seagate Technology and Boston Scientific, and fully exited stakes in Fiserv, Eli Lilly, ICICI Bank and Howard Hughes. Health-care specialist Baker Brothers Advisors kept oncology firm ONC at roughly 20 percent of assets but lifted positions in Insmed by 43 percent, Summit Therapeutics by 38 percent and Celcuity by 42 percent. Among other managers, Mohnish Pabrai’s firm increased Valaris by 32 percent and Alpha Metallurgical Resources by 11 percent while maintaining a 30 percent weighting in Warrior Met Coal. Samantha McLemore’s Patient Capital Management added 31 percent to Norwegian Cruise Line and opened new stakes in UnitedHealth and Telecom Egypt, exiting New Fortress Energy. AKO Capital raised Intuit by 22 percent, trimmed Thermo Fisher Scientific by 92 percent and sold out of Accenture. Triple Frond Partners increased its Meta Platforms holding by 44 percent and cut TransDigm by 20 percent, while Emeth Value Capital maintained Driven Brands at 37 percent of assets and boosted SeatGeek by 27 percent.